Advertisement

Lymphocyte Crossmatching by Flow Cytometry

Protocol
First Online:
Part of the Methods in Molecular Biology book series (MIMB, volume 1034)

Abstract

Flow cytometry is an invaluable tool for studying lymphocyte biology. In transplantation, flow cytometry represents the most sensitive method for demonstrating the binding of HLA antibodies to cellular targets. Referred to as the flow cytometric crossmatch (FCXM), the implementation of this method has revolutionized HLA antibody assessments and facilitated increased allograft survival among highly sensitized recipients. Here we describe the methods for performing the FCXM and discuss its critical aspects, as well as the presentation of data and interpretation of results.

Key words

Flow cytometry Lymphocyte Crossmatch Anti-human IgG HLA Alloantibody Transplantation 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Gebel HM, Bray RA (2010) The evolution and clinical impact of human leukocyte antigen technology. Curr Opin Nephrol Hypertens 19:598–602PubMedCrossRefGoogle Scholar
  2. 2.
    Garovoy MR, Rheinschmilt MA, Bigos M, Perkins H, Colombe B, Feduska N, Salvatierra O (1983) Flow cytometry analysis: a high technology crossmatch technique facilitating transplantation. Transplant Proc 15:1939Google Scholar
  3. 3.
    Cook DJ, Terasaki PI, Iwaki Y, Terashita GY, Lau M (1987) An approach to reducing early kidney transplant failure by flow cytometry crossmatching. Clin Transplantation 1:253–258Google Scholar
  4. 4.
    Bray RA, Lebeck LK, Gebel HM (1989) The flow cytometric crossmatch: dual color analysis of T and B cell reactivities. Transplantation 48:834–840PubMedCrossRefGoogle Scholar
  5. 5.
    Gebel HM, Bray RA, Nickerson P (2003) Pretransplant assessment of donor reactive HLA-specific HLA antibodies in renal ­transplantation: contraindication vs risk. Am J Transplant 3:1488–1500PubMedCrossRefGoogle Scholar
  6. 6.
    Bray RA, Tarsitani C, Gebel HM, Lee JH (2011) Clinical cytometry and progress in HLA antibody detection. Methods Cell Biol 103:285–310PubMedCrossRefGoogle Scholar
  7. 7.
    Lobo P, Spencer CE, Stevenson WC et al (1995) The use of Pronase digested ­lymphocytes to improve the specificity of the flow cytometric crossmatch. Tranplant Int 8:472CrossRefGoogle Scholar
  8. 8.
    Vaidya S, Cooper TY, Avandsalehi J, Barnes T, Brooks K, Hymel P, Noor M, Sellers R, Thomas A, Stewart D, Daller J, Fish JC, Gugliuzza KK, Bray RA (2001) Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation. Transplantation 71(3):422–428PubMedCrossRefGoogle Scholar
  9. 9.
    Liwski R, Adams G, Peladeau G, Eckels D, Bray R, Gebel H (2011) An Optimized flow cytometric crossmatch assay expedites ­pre-transplant immunologic risk assessment. Hum Immunol 72(suppl. 1):s48Google Scholar
  10. 10.
    Liwski R, Pochinco D, Tinckam K, Gebel H, Campbell P, Nickerson P (2012) Canada-wide evaluation of rapid optimized flow crossmatch (rofcxm) protocol. Hum Immunol 73(suppl. 1):26Google Scholar
  11. 11.
    Zachary AA, Lucas DP, Detrick B, Leffell MS (2009) Naturally occurring interference in Luminex assays for HLA-specific antibodies: characteristics and resolution. Hum Immunol 70(7):496–501PubMedCrossRefGoogle Scholar
  12. 12.
    Schnaidt M, Weinstock C, Jurisic M et al (2011) HLA antibody specification using single-­antigen beads—a technical solution for the prozone effect. Transplantation 92(5):510–515PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  1. 1.Department of PathologyEmory University HospitalAtlantaUSA

Personalised recommendations

Cite protocol

Buy options